CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology

CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology

ash

3 months
76 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Shouryadeep Srivastava, MBBS, PhD of @TakedaOncology discusses CML patients prescribed ponatinib vs bosutinib.

Up Next Autoplay